Alain Cribier
After introducing balloon dilatation of centric aortic valves, he conceived and developed TAVI, the transcatheter delivery of an aortic bioprosthesis anchored in situ via a stented frame. This procedure was proven to be life-saving in inoperable patients and can now be offered to patients with high or moderate surgical risk.
In remembrance of Alain Cribier
Latest contributions
Pioneers in TAVI
09 Sep 2024
Meet some of the first generation of pioneers that have inspired many thousands of interventionalists and learn more about the many obstacles they were obliged to along their journey.
In remembrance of Alain Cribier
17 Feb 2024
It is with great sadness that PCR and the interventional cardiology community learnt of the death of Professor Alain Cribier, pioneer in the non-invasive treatment of valvular disease, superb doctor and professor of medicine and great humanist whose concern and care for his patients went beyond...
EuroPCR 2023 Hotlines / Late-Breaking Trials: TAVI
16 May 2023 – From EuroPCR 2023
Discover the conclusions of various studies and registries about TAVI: 5-year outcomes with the ACURATE neo2 valve: the Neo AS CE-mark study; TAVR in patients with cardiogenic shock which evaluated outcomes of consecutive TAVRs in patients with CS using contemporary SAPIEN 3 and SAPIEN 3 ultra...
Twenty years of progress - What we have achieved - LIVE case
27 Nov 2022 – From PCR London Valves 2022
- Part 1: TAVI by axillary access (Live)
An 80-year-old female with peripheral arterial disease presents a symptomatic severe aortic stenosis with small annulus and preserved LV function.
The operators implant, by axillary access, an Evolut pro 26 mm, on general anaesthesia, with predilatation (Balloon 18 mm) and post-dilatation...
The Future of TAVI
19 May 2022 – From EuroPCR 2022
Consut this session if you want to appraise the originality of the TAVI concept, to learn the feasibility of minimalist procedure and fast track patient pathway and to understand the expansion of indications and the future of TAVI.
20 years of TAVI - Revolutionising medicine since 2002
18 May 2022
Twenty years ago, surgical aortic valve replacement (SAVR) was the only real option for patients with symptomatic aortic stenosis, and if the patient was considered at high operative risk, alternatives were very limited.
Author
Author
Author
Author
EuroPCR 2022 Welcome Ceremony
17 May 2022 – From EuroPCR 2022
It is with emotion that William Wijns and Jean Fajadet opened this new edition of EuroPCR, which introduced a hybrid format, combining on-site and online learning. "Spark" is the key word for this EuroPCR 2022, which aims to put the spotlight on nurses and allied professionals,...
Special procedures: transcaval access
17 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about the management of transcaval access and closure for your TAVI patients, and discover various solutions and devices to cope with most complications and plan ahead for all eventualities.
TAVI in horizontal aorta
22 May 2019 – From EuroPCR 2019
Consult this session to discover a LIVE demonstration from St. Johannes Hospital - Dortmund, Germany, regarding TAVI in horizontal aorta, transmitted live during EuroPCR 2019. The patient here is a 78 years-old male presenting with progressive dyspnea (NYHA III) and angina pectoris (CCS-III), whose echography shows...
Keynote lecture: Defining high bleeding risk in patients undergoing PCI: a consensus from the Academic Research Consortium for high bleeding risk
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about high bleeding risk in patients undergoing PCI with this study from the Academic Research Consortium.
Bicuspid aortic stenosis: from imaging to TAVI
21 May 2019 – From EuroPCR 2019
Consult this session on bicuspid aortic stenosis to learn more about the roles of imaging and TAVI to treat it, from implantation to clinical outcomes, thanks to a selection of compelling cases and studies.
Trials and registries - Long term clinical outcomes after TAVI
21 May 2019 – From EuroPCR 2019
Consult this session to learn about the latest trials and registries regarding the long term clinical outcomes after TAVI, such as CHOICE, INTeNSE, RASTAVI, and more!
TAVI: a fascinating 20-year-long odyssey with a happy ending
10 Nov 2017
This new "disruptive" technology is among the most important medical breakthroughs to date. TAVI emerged in 2002 to profoundly alter the landscape of cardiovascular medicine.
First FIM Percutaneously Implanted Heart Valve (PHV) implantation on 16 April, 2002
07 Nov 2017
On April 16, 2002, at the Charles Nicolle University Hospital in Rouen, France, the Interventional Cardiologist, Professor Alain Cribier performed the first transcatheter aortic valve replacement procedure in the world. He used a Prosthetic valve thrombosis (PVT) percutaneous heart valve.
Author
Alain G. Cribier
07 Nov 2017
In 2002, Alain Cribier revolutionised the field by introducing transcatheter aortic valve implantation (TAVI) as a complementary technique to surgery. Find out more about his early life and studies.
Andreas Grüntzig Ethica Awardees
19 Jul 2017
Discover the list of all the Andreas Grüntzig Ethica Awardees.
